How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Algorithms give computers step-by-step instructions to complete tasks accurately.Good algorithms improve software speed, ...

Statistics are the skeleton of your business, but narratives are its soul. Algorithms are now sophisticated enough to look ...

The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, ...

Anthropic PBC has sounded the alarm on the rapid pace of artificial intelligence development and is calling on the world’s ...

In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...

That convenience and lack of clarity were hard to miss in AI.com’s Super Bowl ad and in the explanation of the company’s ...

Image courtesy by QUE.com As we move through 2026, the intersection of blockchain technology and quantum computing has moved ...

Anthropic published an interesting blog post titled "When AI Builds Itself." a couple of days ago, and if you work in financial services and haven't read it, stop what you're doing. The piece ...

The global race toward advanced artificial intelligence is entering a fundamentally new phase. Beyond today's agentic AI ...